ADVFN ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.

ORÈGE joins NYSE Euronext

Share On Facebook
share on Linkedin
Print

Shares was set at €3.24 per share

ORÈGE, a French company and global player that designs, develops and industrializes innovative technological solutions for the treatment of complex effluents and sludge has joined NYSE Euronext’s regulated market in Paris.

Set up in 2005 by its three founding partners, ORÈGE now has 43 employees. The company works in two complementary areas: treatment of complex industrial effluents, and conditioning, treatment and recovery of municipal and industrial sludge. ORÈGE has used its innovation platform to develop two breakthrough technologies, both protected by several patents: SOFHYSm a technology for treating complex, toxic and/or non-biodegradable effluents and SLG, a technology for conditioning sludge.

The company argues that these “treatment solutions offer municipalities and industrial businesses a real alternative to conventional treatment technologies: they are designed to be both more cost-effective and to meet new regulatory and environmental requirements”.

ORÈGE (ticker: OREGE) was listed through the admission to trading of 6,455,306 existing shares and 6,211,420 new shares issued under a Global Offering after the full exercise of the Extension option and before any exercise of the Over-allotment option. It followed the company’s transfer from the Free Market. The Global Offering raised around €20.1 million.

The admission and issue price of ORÈGE shares was set at €3.24 per share. Market capitalisation stood at around €57.7 million on the day of listing.

“We are all the more delighted with ORÈGE’s listing in that it is the first cleantech business outside renewable energies to list on our European market. This new step in the company’s development will enable it to remain at the cutting edge in its field and pursue growth in the fast-growing market for treatment of complex effluents and sludge for industry and municipalities, where regulatory requirements are increasingly strict” said Marc Lefèvre, Head of European Business Development and Client Coverage, Listings Europe, at NYSE Euronext. “NYSE Euronext is committed to serving small and medium-sized companies at all times, to facilitate their access to the market, enhance their visibility and improve the tradability of their shares.”

Pascal Gendrot, Co-founder and CEO of ORÈGE, added: “Listing represents a major step ahead in our company’s business development, and is clearly a springboard for structuring new strategic partnerships. Today ORÈGE is France’s first and only 100% cleantech company to list in Paris, and I would like to thank all of our staff and partners for investing in this tremendous project. I would also like to thank EREN S.A. and its main shareholder Mr Pâris Mouratoglou for the trust they have shown by investing in our company as we make our market debut.”

CLICK HERE TO REGISTER FOR FREE ON ADVFN, the world's leading stocks and shares information website, provides the private investor with all the latest high-tech trading tools and includes live price data streaming, stock quotes and the option to access 'Level 2' data on all of the world's key exchanges (LSE, NYSE, NASDAQ, Euronext etc).

This area of the ADVFN.com site is for independent financial commentary. These blogs are provided by independent authors via a common carrier platform and do not represent the opinions of ADVFN Ltd. ADVFN Ltd does not monitor, approve, endorse or exert editorial control over these articles and does not therefore accept responsibility for or make any warranties in connection with or recommend that you or any third party rely on such information. The information available at ADVFN.com is for your general information and use and is not intended to address your particular requirements. In particular, the information does not constitute any form of advice or recommendation by ADVFN.COM and is not intended to be relied upon by users in making (or refraining from making) any investment decisions. Authors may or may not have positions in stocks that they are discussing but it should be considered very likely that their opinions are aligned with their trading and that they hold positions in companies, forex, commodities and other instruments they discuss.

Leave A Reply

 
Do you want to write for our Newspaper? Get in touch: newspaper@advfn.com